Perspective Therapeutics (CATX) Assets (2011 - 2026)
Perspective Therapeutics (CATX) posted Assets of $410.8 million for Q1 2026, up 53.86% sequentially from $267.0 million in Q4 2025, and up 24.72% YoY from $329.3 million in Q1 2025.
Perspective Therapeutics (CATX) Assets (2011 - 2026) Analysis & Trends
Perspective Therapeutics has reported Assets for 16 years, with the latest figure at $410.8 million in Q1 2026.
- Quarterly Assets rose 24.72% year-over-year to $410.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $410.8 million (up 24.72% YoY) and the FY2025 annual result came in at $267.0 million, down 21.73% from the prior year.
- Assets improved to $410.8 million in Q1 2026 per CATX's latest filing, from $267.0 million in the prior quarter.
- Over five years, Assets peaked at $410.8 million in Q1 2026 and troughed at $58.1 million in Q4 2022.
- A 5-year average of $218.6 million and a median of $267.0 million in 2025 frame the typical range for Assets.
- The sharpest annual moves came in 2024 and 2025: Assets surged 253.93% in 2024, then dropped 24.63% in 2025.
- Over 5 years, Assets stood at $58.1 million in 2022, then surged by 68.51% to $97.9 million in 2023, then jumped by 248.45% to $341.1 million in 2024, then declined by 21.73% to $267.0 million in 2025, then jumped by 53.86% to $410.8 million in 2026.
- According to Business Quant data, Assets over the past three periods registered $410.8 million, $267.0 million, and $294.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 47.93 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 13.87 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 6.46 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 37.25 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 31.04 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 10.74 Bn |
| 10 | Perspective Therapeutics | 389.10 Mn | 389.10 Mn | - | 392.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 392.03 Mn |
| Mar 31, 2026 | 410.77 Mn |
| Dec 31, 2025 | 266.97 Mn |
| Sep 30, 2025 | 294.83 Mn |
| Jun 30, 2025 | 310.73 Mn |
| Mar 31, 2025 | 329.35 Mn |
| Dec 31, 2024 | 341.10 Mn |
| Sep 30, 2024 | 391.15 Mn |
| Jun 30, 2024 | 385.92 Mn |
| Mar 31, 2024 | 278.29 Mn |
| Dec 31, 2023 | 97.89 Mn |
| Sep 30, 2023 | 110.52 Mn |
| Jun 30, 2023 | 120.15 Mn |
| Mar 31, 2023 | 127.65 Mn |
| Dec 31, 2022 | 58.09 Mn |
| Sep 30, 2022 | 62.54 Mn |
| Jun 30, 2022 | 64.44 Mn |
| Mar 31, 2022 | 66.11 Mn |
| Dec 31, 2021 | 67.25 Mn |
| Sep 30, 2021 | 68.71 Mn |